No Data
No Data
Pharmaxis Ltd Highlights Uncertainties in Syntara's Future Projections
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Pharmaxis Ltd Announces Substantial Shareholding Disclosure
Canaccord Genuity Sticks to Their Buy Rating for Pharmaxis Ltd (SNT)
Pharmaxis Ltd Reveals Interim Results at Hematology Forum
Pharmaxis Ltd Director Increases Stock Options